インスリン抵抗性（Insulin Resistance）：グローバル臨床試験レビュー（2014年上半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Insulin Resistance 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Insulin Resistance to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Insulin Resistance to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Insulin Resistance 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Insulin Resistance Therapeutics Clinical Trials 32
Prominent Drugs 34
Latest Clinical Trials News on Insulin Resistance 35
Oct 19, 2011: Genfit Announces Hospital-Based Clinical Study Demonstrates Action Of GFT505 On Liver 35
Aug 19, 2010: Limerick BioPharma Announces Positive Phase 1b Data for LIM-0705 in Preventing 35
Toxicities Associated with the Transplant Drug, Tacrolimus. 35
Clinical Trial Profiles 37
Clinical Trial Overview of Top Companies 37
Merck & Co., Inc. 37
Clinical Trial Overview of Merck & Co., Inc. 37
Bristol-Myers Squibb Company 38
Clinical Trial Overview of Bristol-Myers Squibb Company 38
GlaxoSmithKline plc 39
Clinical Trial Overview of GlaxoSmithKline plc 39
AstraZeneca PLC 40
Clinical Trial Overview of AstraZeneca PLC 40
Royal DSM N.V. 41
Clinical Trial Overview of Royal DSM N.V. 41
Genfit SA 42
Clinical Trial Overview of Genfit SA 42
Harbor Diversified, Inc. 43
Clinical Trial Overview of Harbor Diversified, Inc. 43
F. Hoffmann-La Roche Ltd. 44
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 44
E. I. du Pont de Nemours and Company 45
Clinical Trial Overview of E. I. du Pont de Nemours and Company 45
Clinical Trial Overview of Top Institutes / Government 46
The National Institute of Diabetes and Digestive and Kidney Diseases 46
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 46
National Heart, Lung, and Blood Institute 47
Clinical Trial Overview of National Heart, Lung, and Blood Institute 47
Stanford University 48
Clinical Trial Overview of Stanford University 48
Academic Medical Center 49
Clinical Trial Overview of Academic Medical Center 49
Mayo Clinic 50
Clinical Trial Overview of Mayo Clinic 50
Vanderbilt University 51
Clinical Trial Overview of Vanderbilt University 51
Aarhus University 52
Clinical Trial Overview of Aarhus University 52
University of California, San Francisco 53
Clinical Trial Overview of University of California, San Francisco 53
Maastricht University Medical Center 54
Clinical Trial Overview of Maastricht University Medical Center 54
Massachusetts General Hospital 55
Clinical Trial Overview of Massachusetts General Hospital 55
Five Key Clinical Profiles 56
Appendix 75
Abbreviations 75
Definitions 75
Research Methodology 76
Secondary Research 76
About GlobalData 77
Contact Us 77
Disclaimer 77
Source 77